Dzmitry Skazau/iStock via Getty Images
Arcutis Biotherapeutics (NASDAQ:ARQT) rose 12% amid some takeover speculation.
The biotech is speculated to have attracted some takeover interest, according to traders, who cited a Betaville “uncooked” alert that circulated on Wednesday. An unidentified European company is said to be interested.
